420: Andexanet Alfa Versus 4F-PCC for Direct Anticoagulation Reversal in Intracranial Hemorrhage
Recommended Citation
Rajpal H, Dilip D, Huang A, Yang J, Liu W, Gozum N, Mammadli G, Bond C, Mehta H, Mayer S. 420: Andexanet Alfa Versus 4F-PCC for Direct Anticoagulation Reversal in Intracranial Hemorrhage. Crit Care Med 2026; 54(3S).
Document Type
Conference Proceeding
Publication Date
3-1-2026
Publication Title
Crit Care Med
Keywords
anticoagulation reversal, article, brain hemorrhage, human, andexanet alfa
Volume
54
Issue
3S
